Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Discontinuation of Imatinib: A Tyrosine Kinase Inhibitor Withdrawal Syndrome? Reply

被引：11

作者：

Rousselot, Philippe ^{[1
]}

Charbonnier, Aude ^{[2
]}

Cony-Makhoul, Pascale ^{[3
]}

Agape, Philippe ^{[4
]}

Nicolini, Franck E. ^{[5
]}

Varet, Bruno ^{[6
,7
]}

Gardembas, Martine ^{[8
]}

Etienne, Gabriel ^{[9
]}

Rea, Delphine ^{[10
]}

Roy, Lydia ^{[11
]}

Escoffre-Barbe, Martine ^{[12
]}

Guerci-Bresler, Agnes ^{[13
]}

Tulliez, Michel ^{[14
]}

Prost, Stephane ^{[15
]}

Spentchian, Marc ^{[16
]}

Cayuela, Jean Michel ^{[10
]}

Reiffers, Josy ^{[17
]}

Chomel, Jean Claude ^{[18
,19
]}

Turhan, Ali ^{[18
,19
]}

Guilhot, Joelle ^{[20
]}

Guilhot, Francois ^{[20
]}

Mahon, Francois-Xavier ^{[21
,22
]}

机构：

[1] Univ Versailles St Quentin en Yvelines, Hop Mignot, Versailles, France

[2] Inst Paoli Calmette, Marseille, France

[3] Hop Annecy, Pringy, France

[4] Ctr Hop Univ CHU Reunion, Hop Felix Guyon, St Pierre, Reunion, France

[5] Ctr Hosp Lyon Sud, Pierre Benite, France

[6] Hop Necker Enfants Malad, AP HP, Paris, France

[7] Univ Paris 05, Paris, France

[8] CHU Angers, Angers, France

[9] Inst Bergonie, Bordeaux, France

[10] Hop St Louis, AP HP, Paris, France

[11] CHU Poitiers, INSERM, Clin Invest Ctr CIC 802, Poitiers, France

[12] Ctr Hosp Pontchaillou, Rennes, France

[13] CHU Brabois Vandoeuvre, Nancy, France

[14] Hop Henri Mondor, AP HP, Paris, France

[15] Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France

[16] Hop Mignot, Le Chesnay, France

[17] Inst Bergonie, Bordeaux, France

[18] Univ Poitiers, INSERM U935, Le Kremlin Bicetre, France

[19] Univ Paris 11, Le Kremlin Bicetre, France

[20] CHU Poitiers, INSERM CIC 802, Poitiers, France

[21] Hop Haut Leveque, INSERM U1035, Bordeaux, France

[22] Univ Bordeaux Segalen, Bordeaux, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 25期

关键词：

COMPLETE MOLECULAR REMISSION; CHRONIC MYELOGENOUS LEUKEMIA; MESYLATE; THERAPY; DISEASE;

D O I：

10.1200/JCO.2014.56.3858

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2823 / +

页数：3

共 50 条

[1] Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Discontinuation of Imatinib: A Tyrosine Kinase Inhibitor Withdrawal Syndrome?
Richter, Johan
Soderlund, Stina
Lubking, Anna
Dreimane, Arta
Lotfi, Kourosh
Markevarm, Berit
Sjalander, Anders
Saussele, Susanne
Olsson-Stromberg, Ulla
Stenke, Leif
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2821 - 2823
[2] Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia
Chelysheva, Ekaterina Yu
Petrova, Anna N.
Shukhov, Oleg A.
Bykova, Anastasiia, V
Nemchenko, Irina S.
Gurianova, Margarita A.
Tsyba, Nikolay N.
Turkina, Anna G.
TERAPEVTICHESKII ARKHIV, 2022, 94 (07) : 836 - 843
[3] Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Tyrosine Kinase Inhibitor Therapy Cessation
Kota, Vamsi
Atallah, Ehab
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (08): : 480 - 487
[4] Musculoskeletal pain may be associated with imatinib withdrawal syndrome in chronic myeloid leukemia patients
Ishii, Yoshimi
Hagihara, Maki
Kato, Ai
Ando, Taiki
Itabashi, Megumi
Koyama, Satoshi
Yamamoto, Wataru
Motohashi, Kenji
Matsumoto, Kenji
Fujisawa, Shin
LEUKEMIA & LYMPHOMA, 2016, 57 (02) : 496 - 497
[5] Tyrosine Kinase Inhibitor Withdrawal Syndrome in Chronic Myeloid Leukemia Patients Participants of Two Discontinuation Clinical Trials
Murbach, Bruna A.
Guidini, Victor H.
Palma, Leonardo Carvalho
Miranda, Eliana C. M. C. M.
Oliveira, Gislaine Borba
Amarante, Guilherme D.
Furlin, Graziele C. P.
Toni, Isabella Macedo
De Souza, Carmino
Figueiredo-Pontes, Lorena
Pagnano, Katia B.
BLOOD, 2023, 142
[6] Increased values of the circulating PDGFβ sustains the "withdrawal syndrome" after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia
Galimberti, Sara
Fontanelli, Giulia
Barsotti, Sara
Ricci, Federica
Guerrini, Francesca
Barate, Claudia
BLOOD CELLS MOLECULES AND DISEASES, 2015, 55 (03) : 211 - 212
[7] Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI
Petrova, Anna
Chelysheva, Ekaterina
Shukhov, Oleg
Bykova, Anastasiya
Nemchenko, Irina
Gusarova, Galina
Tsyba, Nikolay
Julhakyan, Hunan
Shuvaev, Vasiliy
Fominykh, Mikhail
Martynkevich, Irina
Ionova, Tatyana
Turkina, Anna
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (05): : E267 - E271
[8] Chronic Myeloid Leukemia—the Promise of Tyrosine Kinase Inhibitor Discontinuation
Ravi Kishore Narra
Kathryn E. Flynn
Ehab Atallah
Current Hematologic Malignancy Reports, 2017, 12 : 415 - 423
[9] Second Tyrosine Kinase Inhibitor Discontinuation Attempt in Patients With Chronic Myeloid Leukemia
Legros, Laurence
Nicolini, Franck E.
Etienne, Gabriel
Rousselot, Philippe
Rea, Delphine
Giraudier, Stephane
Guerci-Bresler, Agnes
Huguet, Francoise
Gardembas, Martine
Escoffre, Martine
Ianotto, Jean-Christophe
Noel, Marie-Pierre
Varet, Bruno R.
Pagliardini, Thomas
Touitou, Irit
Morisset, Stephane
Mahon, Francois-Xavier
CANCER, 2017, 123 (22) : 4403 - 4410
[10] Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia
Flynn, Kathryn E.
Atallah, Ehab
Lin, Li
Shah, Neil P.
Silver, Richard T.
Larson, Richard A.
Panilla-Ibarz, Javier
Thompson, James E.
Oehler, Vivian G.
Radich, Jerald P.
Kota, Vamsi
Mauro, Michael J.
Schiffer, Charles A.
Cortes, Jorge
Weinfurt, Kevin P.
HAEMATOLOGICA, 2022, 107 (11) : 2641 - 2649

← 1 2 3 4 5 →